As volatility creeps into cbdMD, Inc. (NYSE:YCBD), investors need to pay close attention to to the factors affecting stock today as its shares are trading 4.18% or 0.046 points up from last closing price of $1.09, reaching $1.1356 at last check. The YCBD share price is gaining for the third day in a row and has risen in 3 of the last 5 days and is down -69.3% over the past week. It will be exciting to see whether the stock manages to continue increasing or take a minor break for the next few days. The move came on weak volume too with far less shares changing hands than in a normal session. Trading activity as of this writing weakened by -1,006,526 shares, and in total 974574 shares valued at $1.107 million were seen changing hands compared with 1.981 million shares valued at $2.159 million recorded at the previous session. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes in YCBD stock for the next couple of days.
cbdMD, Inc. (YCBD) shares have notched a 3-month decline of about -69.3%, but has still tumbled -51.77% year to date. By comparison, the stock sank -74.05% over the past 12 months, while it slipped -61.62% over the 1 month. The company’s market cap is around $40.78M, with its short interest ratio standing at 7.89%.
In the current trading session for YCBD, the stock witnessed two major price actions, it rose to a high of $1.19 and was down as much as $1.1 at one point. The high recorded is very low when compared to their 52-week high which is $0.99. The 52-week high is now at -84.39 distance from current price. Their recent low of $7.24 represents a 14.15% recovery. This data is quite important for investors who look to benefit from the recent rise of the company’s stock. The price target currently for YCBD is $6.13, this is below the recent high that the stock attained. Taking a look at the overall sentimental views of financial analysts, the trading pattern of this stock recently is very clear.
The stock of cbdMD, Inc. earned $-2.37 per share in the trailing 12 months and has a P/E ratio of -0.48. You can compare it with that of similar companies in its industry to get a sense of whether the stock you’re looking to purchase is overvalued or undervalued. Its current price to earnings ratio is lower than the ones recorded by the industry which is 42.6 and lower compared to the sector’s average of 29.77. When the P/E ratio is low let’s say below 1.0, then the stock price is considered a good value. YCBD also has P/S multiple of 1.79. This is greater versus the 12 month P/S ratios of other companies in the same indutry. The peer average price to sales ratio is 0.85x.
YCBD‘s last price was down -73.87% as compared to the average trading price of 50 days recorded at $4.35 while enlarging the period to 200 trading days, the average closing price was $2.84. At present, there are 37.41 million in the total number of common shares owned by the public and among those 20.25 million shares have been available to trade. The percentage of shares being held by the company management was 26.95% while institutions stake was 12.8%. The company has generated negative returns on equity over the last 12 months (-309.9%). It managed to keep its gross profit margin at 61.4% over the past 12 months.
When assessing the full upside of the YCBD stock, there is another set of technicals that should be looked into and considered. Its -48.09% decline from moving average of $2.19 has brought about a negative sentiment when calculated over the last 20 days. The market has allocated a beta of 0 to the stock. With the beta been less than one, this implies that the company shares are theoretically less volatile than the market, something that the traders definitely are keeping an eye on.